DiaMedica Therapeutics In... (DMAC)
NASDAQ: DMAC
· Real-Time Price · USD
3.60
0.09 (2.56%)
At close: Jun 17, 2025, 1:26 PM
DiaMedica Therapeutics Revenue
DiaMedica Therapeutics reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending March 31, 2025, DiaMedica Therapeutics generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
0%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
27
Market Cap
154.38M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|